- Home
- BATRK vs APGE Comparison
BATRK vs APGE Comparison
Compare BATRK & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATRK
- APGE
- Stock Information
- Founded
- BATRK 1991
- APGE 2022
- Country
- BATRK United States
- APGE United States
- Employees
- BATRK N/A
- APGE N/A
- Industry
- BATRK Broadcasting
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BATRK Industrials
- APGE Health Care
- Exchange
- BATRK Nasdaq
- APGE Nasdaq
- Market Cap
- BATRK 2.5B
- APGE 2.1B
- IPO Year
- BATRK N/A
- APGE 2023
- Fundamental
- Price
- BATRK $38.91
- APGE $36.53
- Analyst Decision
- BATRK Strong Buy
- APGE Strong Buy
- Analyst Count
- BATRK 2
- APGE 4
- Target Price
- BATRK $56.50
- APGE $91.33
- AVG Volume (30 Days)
- BATRK 328.0K
- APGE 754.8K
- Earning Date
- BATRK 05-12-2025
- APGE 05-12-2025
- Dividend Yield
- BATRK N/A
- APGE N/A
- EPS Growth
- BATRK N/A
- APGE N/A
- EPS
- BATRK N/A
- APGE N/A
- Revenue
- BATRK $662,748,000.00
- APGE N/A
- Revenue This Year
- BATRK $7.24
- APGE N/A
- Revenue Next Year
- BATRK $5.65
- APGE $743.14
- P/E Ratio
- BATRK N/A
- APGE N/A
- Revenue Growth
- BATRK 3.45
- APGE N/A
- 52 Week Low
- BATRK $35.46
- APGE $26.20
- 52 Week High
- BATRK $44.43
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- BATRK 52.08
- APGE 54.61
- Support Level
- BATRK $37.72
- APGE $31.38
- Resistance Level
- BATRK $38.50
- APGE $34.23
- Average True Range (ATR)
- BATRK 1.32
- APGE 3.15
- MACD
- BATRK 0.11
- APGE 0.40
- Stochastic Oscillator
- BATRK 79.68
- APGE 82.31
About BATRK Atlanta Braves Holdings Inc. Series C
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include, baseball which generates key revenue, and mixed-use development.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.